David Yanni

2PUBLICATIONS
2CO-AUTHORS
Disease surveillanceOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jul 15, 2026
Azacitidine Is Well-Tolerated and Is Associated with High Response Rate in Elderly Patients with Higher-Risk Myelodysplastic Syndromes: A Single Center Observational Study.

|Mar 14, 2026
Addition of Venetoclax to Azacitidine Did Not Improve Survival in Acute Myeloid Leukemia and Was Not Well Tolerated: Real World Experience.

David Yanni, Nupur Krishnan, Rouslan Kotchetkov

Pageof 1

Frequent Collaborators

2 joint publications

Rouslan Kotchetkov

1 joint publications

Nupur Krishnan